Bicycle Therapeutics (BCYC) Gains from Investment Securities: 2018-2025
Historic Gains from Investment Securities for Bicycle Therapeutics (BCYC) over the last 5 years, with Sep 2025 value amounting to $233,000.
- Bicycle Therapeutics' Gains from Investment Securities fell 24.84% to $233,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 86.26%. This contributed to the annual value of -$1.5 million for FY2024, which is 137.30% down from last year.
- Per Bicycle Therapeutics' latest filing, its Gains from Investment Securities stood at $233,000 for Q3 2025, which was up 120.02% from -$1.2 million recorded in Q2 2025.
- Bicycle Therapeutics' Gains from Investment Securities' 5-year high stood at $13.8 million during Q4 2021, with a 5-year trough of -$2.6 million in Q4 2024.
- In the last 3 years, Bicycle Therapeutics' Gains from Investment Securities had a median value of -$31,500 in 2023 and averaged $972,426.
- As far as peak fluctuations go, Bicycle Therapeutics' Gains from Investment Securities spiked by 44,905.53% in 2021, and later slumped by 459.62% in 2025.
- Over the past 5 years, Bicycle Therapeutics' Gains from Investment Securities (Quarterly) stood at $13.8 million in 2021, then tumbled by 36.98% to $3.1 million in 2022, then soared by 87.47% to -$106,000 in 2023, then skyrocketed by 392.45% to -$2.6 million in 2024, then declined by 24.84% to $233,000 in 2025.
- Its last three reported values are $233,000 in Q3 2025, -$1.2 million for Q2 2025, and $43,000 during Q1 2025.